0001127602-20-018902.txt : 20200604
0001127602-20-018902.hdr.sgml : 20200604
20200604185337
ACCESSION NUMBER: 0001127602-20-018902
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200505
FILED AS OF DATE: 20200604
DATE AS OF CHANGE: 20200604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zaks Tal Zvi
CENTRAL INDEX KEY: 0001690927
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 20944067
MAIL ADDRESS:
STREET 1: 122 BELLEVUE STREET
CITY: NEWTON
STATE: MA
ZIP: 02458
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
4/A
1
form4a.xml
PRIMARY DOCUMENT
X0306
4/A
2020-05-05
2020-05-06
0001682852
Moderna, Inc.
MRNA
0001690927
Zaks Tal Zvi
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
Chief Medical Officer
Common Stock
2020-05-05
4
S
0
4770
50.48
D
0
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on September 26, 2019 and January 21, 2020.
This amendment is being filed to revise footnote 1 included in the original Form 4 referenced herein (the "Original Form 4") to read as set forth in footnote 1 above. The transaction described in Table I of this filing is not new or revised, but is being reported again to gain access to the EDGAR reporting system. Furthermore, the sales referenced in the Forms 4 filed by the reporting person between December 16, 2019 and the date of the Original Form 4 were also effected pursuant to the Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on September 26, 2019 and January 21, 2020 (as applicable).
/s/ Lori Henderson, as Attorney-in-Fact
2020-06-04